Search Results
Mar 03, 2026, 10:30 ET Patient Advocate Foundation and PAN Foundation Announce Merger to Create Nation's Most Comprehensive Nonprofit Dedicated to Helping Patients Navigate, Access, and Afford Care
The nation's largest portfolio of financial assistance programs – providing over 130 disease-specific financial assistance funds for chronic and rare conditions. Best-in-class personalized case management support – helping people, regardless of insurance status, solve real-life challenges related
More news about: Patient Advocate Foundation
Mar 03, 2026, 10:15 ET Interlune and Astrolab Collaborate on Technology for Harvesting Resources and Building Infrastructure on the Moon
using the smallest, most energy-efficient machinery of its kind. Over time, Interlune will harvest additional resources—including industrial metals, rare earth elements, and water—to support a long-term presence on the Moon and a robust in-space economy. The company has raised $18 million to date and
More news about: Interlune
Mar 03, 2026, 10:02 ET Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
life-threatening rare pediatric and chronic aging-related conditions, with programs spanning hypoplastic left heart syndrome, Alzheimer's disease, and pediatric dilated cardiomyopathy. Laromestrocel has received five FDA designations across its pipeline, including Orphan Drug, Fast Track, Rare Pediatric Disease,
More news about: USA News Group
Mar 03, 2026, 10:00 ET The Pentagon's Most Important Tech is No Longer "Made in China"
NB), FMC Corporation (NYSE: FMC), IperionX (NASDAQ: IPX). For decades, China has dominated rare earths — not just because it mined the most, but because it converted rare earth oxides into metal, the final, most critical step that makes it all usable. Anything North America mined had
More news about: OilPrice.com
Mar 03, 2026, 10:00 ET UDOT & SVN Auction Services announce major online auction
access to UDOT's auction-related information. Online bidding for 12 important properties begins March 24 and ends March 31.Among the properties up for auction is a rare opportunity to own over 36 acres strategically located within the Gordon Avenue/Highway 89 Town Center Master Plan in Layton City.Developed
More news about: SVN Auction Services, LLC
Mar 03, 2026, 10:00 ET StimLabs® Announces the Launch of Architect, a Novel Advanced Collagen Matrix Device for Wound Care
expand both our commercial footprint and our product portfolio," said Tom Dion, EVP & Chief Commercial Officer of StimLabs. "Architect offers a rare combination of durability, flexibility, and clinical efficiency - giving providers control over how they manage complex wounds. It's a solution designed
More news about: StimLabs
Mar 03, 2026, 10:00 ET The Mark Foundation Announces $4M in 2026 Drug Discovery Awards
University of California, San FranciscoCreating the first therapies designed to directly disable the primary genetic drivers of uveal melanoma, a rare and lethal eye cancer.TRIM21 E3 Ligase Reprogramming for Cancer TherapySteven Corsello, MD, and Nathanael Gray, PhD,
More news about: The Mark Foundation for Cancer Research
Mar 03, 2026, 09:05 ET After 75 Years in Hiring, Recruiters Say Work Ethic Is the Most Reliable Predictor of Success
75 years of connecting Americans with meaningful work – placing it among the longest-running staffing firms and in the rare one percent of U.S. businesses to reach this milestone.
More news about: HireQuest
Mar 03, 2026, 09:00 ET Shareholders that lost money on Ultragenyx Pharmaceutical Inc.(RARE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
March 3, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE).
More news about: The Gross Law Firm
Mar 03, 2026, 09:00 ET Protego Biopharma Appoints John M. Maraganore, Ph.D., to Board of Directors
Maraganore said. "I'm eager to play a role, especially as Protego advances its lead drug candidate into a pivotal clinical trial for AL amyloidosis, a rare and often fatal condition caused by protein misfolding."Dr. Maraganore was the founding CEO and a Director of Alnylam Pharmaceuticals from 2002
More news about: Protego Biopharma
Mar 03, 2026, 09:00 ET OSULLOC Showcases Full Range of Matcha Products at Natural Products Expo West 2026
Natural Products Expo West 2026. During the expo, OSULLOC will spotlight the evolution of its matcha portfolio, highlighting its rare, fully integrated farm-to-cup model. By owning its organic tea farms and managing the entire process, from cultivation and R&D to production, distribution,
More news about: OSULLOC
Mar 03, 2026, 09:00 ET MVA Welcomes Hudson Bay Capital's Edward Han to Advisory Board
leadership with world-class innovation to help deter conflict and defend the republic," said Ernestine Fu Mak, Co-Founder of MVA. "Ed Han embodies a rare combination of combat experience, Wall Street acumen, and unwavering commitment to national security. He is an inspiration to others, and we are proud
More news about: MilVet Angels
Mar 03, 2026, 09:00 ET PACSUN REIMAGINES SPRING/SUMMER 2026 SWIMWEAR THROUGH GEN Z-LED CO-CREATION
streetwear, and activewear, Pacsun partners with the best brands at the intersection of fashion, music, art, and sport to offer curated collections, rare and exclusive products, and creative collaborations on every level to inspire the next generation. Founded in 1980 in Newport, CA, Pacsun is now co-created
More news about: Pacsun
Mar 03, 2026, 09:00 ET The Ritz-Carlton Yacht Collection Announces Asia and Alaska Itineraries Aboard Luminara for Summer 2027
Wrangell and Klawock, where visits feel unhurried and less crowded. Some itineraries also call on Wrangell during bear season and the salmon run, unlocking rare opportunities for unforgettable wildlife viewing at their peak. Throughout the region, guests can enjoy close connection to the sea from the yacht's
More news about: Marriott International, Inc.
Mar 03, 2026, 08:43 ET VINFAST STRUCTURES ITS AUTOMOTIVE PORTFOLIO INTO THREE STRATEGIC BRAND LINES, UNVEILS TWO NEW ULTRA-LUXURY MODELS
sophisticated brand signature.Inside the cabin, the Lac Hong 800S and 900S are meticulously appointed with top-tier materials including Nappa leather, rare woods and refined gold-plated accents.Both vehicles integrate advanced intelligent technologies and comprehensive safety systems, complemented
More news about: VinFast
Mar 03, 2026, 08:30 ET Theravance Biopharma Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost Reduction Actions
the efficacy and safety of ampreloxetine in patients with symptomatic neurogenic orthostatic hypotension (nOH) due to multiple system atrophy (MSA), a rare disease. The study did not meet its primary endpoint in the Orthostatic Hypotension Symptom Assessment (OHSA) composite score. As a result of this outcome,
More news about: Theravance Biopharma, Inc.
Mar 03, 2026, 08:25 ET Women Power the Growth of Estrella Insurance
its franchisees are women, more than double the national average, as women represent roughly 30% of franchise owners in the U.S. The statistic is both rare and intentional. A Legacy of OpportunityEmpowering immigrants and women has long been embedded in the company's culture. When
More news about: Estrella Insurance
Mar 03, 2026, 08:15 ET Locksley Announces High-Grade Antimony Assays at Desert Antimony Mine Confirm Surface Continuity
https://www.locksleyresources.com.au) is focused on critical minerals in the U.S. The company is actively advancing the Mojave Project in California, targeting rare earth elements (REEs) and antimony. Locksley is executing a mine-to-market strategy for antimony, aimed at reestablishing domestic supply chains for
More news about: Locksley Resources
Mar 03, 2026, 08:01 ET Vanda Announces FDA Grants Landmark Hearing for HETLIOZ® in Jet Lag Disorder, the First Drug Approval Hearing in Over 40 Years
pursuant to 21 CFR § 12.120.Granting a formal evidentiary public hearing in response to a proposed refusal to approve a drug application is a rare and highly significant regulatory step. Publicly available records and historical accounts indicate that the FDA has not granted such a hearing under
More news about: Vanda Pharmaceuticals Inc.
Mar 03, 2026, 08:00 ET China's Rare Earth Dominance and the Strategic Failure of the West
converting rare earths through metallization and alloying at scale, including heavy rare earth elements.That capability sits at its Euclid, Ohio site, where rare earth metals and alloys are already being produced for U.S. government customers.This is the step in the chain where rare earths
More news about: OilPrice.com
Mar 03, 2026, 08:00 ET Seedtag Welcomes Brendan McCarthy as Chief Marketing & Communications Officer
believe the future of advertising isn't about tracking people— it's about understanding them," said Brian Gleason, CEO of Seedtag. "Brendan brings the rare ability to turn vision into momentum and innovation into impact. As we expand Liz and our Neuro-Contextual platform globally, his leadership will help
More news about: SEEDTAG ADVERTISING
Mar 03, 2026, 08:00 ET Basware Names Donna Wilczek New Chief Product and Technology Officer
our approach to Invoice Lifecycle Management and secure our rankings as the #1 provider among Gartner, Forrester and IDC. She brings a rare combination of deep domain expertise, customer obsession, and a builder's mindset - exactly what we need as we create the future of intelligent finance
More news about: Basware
Mar 03, 2026, 08:00 ET Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference
dystrophin. Sevasemten has achieved notable regulatory milestones by securing FDA Orphan Drug Designation for the treatment of Becker and Duchenne, Rare Pediatric Disease Designation (RPDD) for the treatment of Duchenne, and Fast Track designations for the treatment of Becker and Duchenne. Further, sevasemten
More news about: Edgewise Therapeutics
Mar 03, 2026, 08:00 ET Avora Residences Acquires Seven Seas Navigator, Announces Launch of Avora Lumina, Setting a New Premium Standard for Residential Cruising
cabins," Petterson said. "They are designed as floating homes — primary residences that travel with their owners for years at a time."A Rare Platform in the Global FleetWith its size and configuration, Avora Lumina occupies a distinctive position within the global passenger
More news about: Avora Residences
Mar 03, 2026, 07:59 ET Pierre Fabre Pharmaceuticals Submits Type A Meeting Request to U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA)
meeting with the agency to discuss a path forward that achieves accelerated approval of tabelecleucel in R/R EBV+ PTLD. People living with this ultra-rare form of lymphoma urgently need an FDA-approved treatment option as none currently exist," said Adriana Herrera, Chief Executive Officer of Pierre Fabre
More news about: Pierre Fabre Pharmaceuticals